Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors

Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure

NCT03323541 ·Status: COMPLETED

Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma

NCT01769911 ·Status: WITHDRAWN ·Phase: NA

Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders

NCT00006056 ·Status: UNKNOWN ·Phase: NA

Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

NCT00603330 ·Status: RECRUITING ·Phase: PHASE2

Herpes Zoster Vaccine for Bone Marrow Transplant Donors

NCT01573182 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Participants

NCT00284986 ·Status: COMPLETED ·Phase: PHASE2

Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes

NCT07228624 ·Status: RECRUITING ·Phase: PHASE2

Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation

NCT03663933 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT02960646 ·Status: COMPLETED ·Phase: PHASE1

Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder

NCT06414889 ·Status: RECRUITING ·Phase: PHASE1

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

NCT01413568 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

NCT00785525 ·Status: RECRUITING ·Phase: PHASE3

Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors

NCT01158118 ·Status: COMPLETED ·Phase: PHASE2

Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies

NCT01751243 ·Status: WITHDRAWN ·Phase: PHASE1

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

NCT01696461 ·Status: COMPLETED ·Phase: PHASE2

T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders

NCT00176826 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01076270 ·Status: TERMINATED ·Phase: NA

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

NCT01374841 ·Status: UNKNOWN ·Phase: PHASE2

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

NCT00238433 ·Status: COMPLETED ·Phase: PHASE2

Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder

NCT00049634 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

NCT00055653 ·Status: COMPLETED ·Phase: PHASE2

Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy

NCT06851767 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2

Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

NCT00002833 ·Status: COMPLETED ·Phase: PHASE2

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

NCT00253552 ·Status: TERMINATED ·Phase: NA

A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis

NCT02172963 ·Status: COMPLETED ·Phase: PHASE1/PHASE2